期刊文献+

COPD合并糖尿病患者血清基质金属蛋白酶-9的变化及相关因素分析 被引量:4

The changes of MMP-9 in the patients with ARDS complicated DM and analysis of relative factors
下载PDF
导出
摘要 目的研究COPD合并糖尿病患者血清基质金属蛋白酶-9(MMP-9)的变化及相关因素分析。方法选择50例COPD患者为研究对象,按是否合并糖尿病分为COPD组(25例),COPD合并糖尿病组(25例),同期体检健康的25例作为正常对照组,检测血清MMP-9,C反应蛋白,血气分析,肺功能变化。结果 COPD组,COPD合并糖尿病组血清MMP-9和CRP水平明显高于对照组,差异有统计学意义(P<0.01)。COPD合并糖尿病组血清MMP-9和CRP水平高于COPD组,差异有统计学意义(P<0.05);COPD组,COPD合并糖尿病组PaO2水平明显低于对照组,PaCO2水平明显高于对照组,差异有统计学意义(P<0.01)。COPD合并糖尿病组PaO2,水平低于COPD组,差异有统计学意义(P<0.05),而两组间PaCO2差异无统计学意义(P>0.05);COPD组,COPD合并糖尿病组肺功能水平明显低于对照组,差异有统计学意义(P<0.01)。COPD合并糖尿病组肺功能水平低于COPD组,差异有统计学意义(P<0.05)。结论 COPD合并糖尿病检测各项指标更差,病情更严重,病死率更高,应该引起足够重视。 Objective To discuss the changes of MMP-9 in the patients with ARDS complicated DM and analysis of relative factors. Methods Fifty patients with COPD were studied, divided into COPD group (n = 25 ) and COPD complicated DM group ( n = 25 ) , 25 cases who were healthy as the normal group, to detect the changes of serum MMP-9,CRP, blood gas analysis,lung function. Results The serum MMP-9,CRP in COPD group, COPD complicated DM group were significantly higher than those in normal group, there were sig- nificant differences (P 〈 O. 01 ), and the serum MMP-9, CRP in COPD complicated DM group were higher than those in COPD group, the differences were statistically significant ( P 〈 0. 05 ). The levels of PaO2 in COPD group, COPD complicated DM group were significantly lower than those in normal group, and the levels of PaCO2were significantly higher than those in normal group, there were significant differences (P 〈0.01 ) , and the levels of PaO2 in COPD complicated DM group were lower than those in COPD group, the differences were statistically significant ( P 〈 0. 05 ), while the levels of PaCO2 had no signillcant difference among the two groups (P 〉 0. 05 ). The levels of lung function in COPD group, COPD complicated DM group were significantly lower than those in normal group,there were significant differences (P 〈 0. 01 ), and the levels of lung function in COPD complicated DM group were lower than those in COPD group, the differences were statistically significant (P 〈 0. 05 ). Conclusion The levels were worse, the illness were more serious, the fatality rates were more higher in patients with COPD complicated DM, and we should take more attentions.
出处 《中国实用医药》 2012年第16期11-13,共3页 China Practical Medicine
  • 相关文献

参考文献12

  • 1慢性阻塞性肺疾病诊治指南[J].中华结核和呼吸杂志,2002,25(8):453-460. 被引量:5103
  • 2陆在英;钟南山.内科学[M]北京:人民卫生出版社,200862-284.
  • 3Wairand S,Guillet C,Boirie Y. The evidences that insulin regulates human polymorphonuclear neutrophil runetions[J].Journal of Leukocyte Biology,2004.1104-1110.
  • 4Sheu JR,Fong TH,Liu CM. Expression of matrix met alloproteinase-9 in human platelets:regulation of platelet activation in vitro and in vivo studies[J].British Journal of Pharmacology,2004,(01):193-201.
  • 5Corbel M,Boichot E,Lagente V. Role of gelatinases MMP-2 and MMP-9 in tissue remodeling following acute lung injury[J].Brazilian Journal of Medical and Biological Research,2000.749-754.
  • 6Higashimoto Y,Iwata T,Okada M. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease[J].Respiratory Medicine,2009,(08):1231-1238.
  • 7Russell RE,Culpitt SV,Dematos C. Release and activity of matrix met alloproteinase-9 and tissue inhibitor of met allopro-teinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease[J].American Journal of Respiratory Cell and Molecular Biology,2002,(05):602-609.
  • 8Marx N,Froehlich J,Siam L. Antidiabetic PPAR gamma-activator rosiglitazone reduces MMP-9 serum levels in type 2 diabetic patients with coronary artery disease[J].Arter ioscler Thromb Vasc Biol,2003.283-288.
  • 9周玉洪,王国忠,严德钧,张高兆,魏烈.451例老年慢阻肺合并2型糖尿病临床特点[J].老年医学与保健,2003,9(4):236-237. 被引量:3
  • 10寿璐,周建英.慢性阻塞性肺疾病合并糖尿病患者肺部真菌感染病原学及易感因素分析[J].中国微生态学杂志,2010,22(7):637-639. 被引量:10

二级参考文献12

共引文献5113

同被引文献29

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部